Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


12.09.2022

2 Aliment Pharmacol Ther
1 Am J Lifestyle Med
1 BMC Womens Health
1 Chin Med J (Engl)
1 Clin Nutr
2 Curr Opin Pharmacol
1 Eur J Health Econ
1 Front Cell Neurosci
1 Front Pharmacol
1 Front Physiol
1 Indian J Gastroenterol
1 J Biol Chem
1 J Parasitol Res
1 Parasit Vectors
1 Phys Med
1 Singapore Med J


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
    Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply.
    Aliment Pharmacol Ther. 2022;56:1217-1218.
    PubMed        

  2. GU Y, Xiang Y
    Letter: efficacy of peppermint oil in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022;56:1215-1216.
    PubMed        


    Am J Lifestyle Med

  3. THOMAS A, Thomas A, Butler-Sanchez M
    Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome.
    Am J Lifestyle Med. 2021;16:608-621.
    PubMed         Abstract available


    BMC Womens Health

  4. DE LAS MERCEDES VILLA ROSERO C, Mazin SC, Nogueira AA, Vargas-Costales JA, et al
    Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador.
    BMC Womens Health. 2022;22:363.
    PubMed         Abstract available


    Chin Med J (Engl)

  5. LIU Z, Zhu S, He M, Li M, et al
    Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity.
    Chin Med J (Engl). 2022 Aug 25. pii: 00029330-990000000-00145.
    PubMed         Abstract available


    Clin Nutr

  6. CHU N, Chan JC, Chow E
    A diet high in FODMAPs as a novel dietary strategy in diabetes?
    Clin Nutr. 2022;41:2103-2112.
    PubMed         Abstract available


    Curr Opin Pharmacol

  7. ALGERA JP, Tornblom H, Simren M
    Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome.
    Curr Opin Pharmacol. 2022;66:102284.
    PubMed         Abstract available

  8. HUSSEIN H, Boeckxstaens GE
    Immune-mediated food reactions in irritable bowel syndrome.
    Curr Opin Pharmacol. 2022;66:102285.
    PubMed         Abstract available


    Eur J Health Econ

  9. MANIPIS K, Mulhern B, Haywood P, Viney R, et al
    Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment.
    Eur J Health Econ. 2022 Sep 8. pii: 10.1007/s10198-022-01512.
    PubMed         Abstract available


    Front Cell Neurosci

  10. ZHAN TT, Dong ZY, Yi LS, Zhang Y, et al
    Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats.
    Front Cell Neurosci. 2022;16:922750.
    PubMed         Abstract available


    Front Pharmacol

  11. BAO W, Qi L, Bao Y, Wang S, et al
    Alleviating insomnia should decrease the risk of irritable bowel syndrome: Evidence from Mendelian randomization.
    Front Pharmacol. 2022;13:900788.
    PubMed         Abstract available


    Front Physiol

  12. YANG H, Hou C, Xiao W, Qiu Y, et al
    The role of mechanosensitive ion channels in the gastrointestinal tract.
    Front Physiol. 2022;13:904203.
    PubMed         Abstract available


    Indian J Gastroenterol

  13. GORKA AM, Nauta F, Bijlsma MW, Taselaar P, et al
    Current treatment practice of functional abdominal pain disorders in children: A multicenter survey.
    Indian J Gastroenterol. 2022 Sep 3. pii: 10.1007/s12664-022-01253.
    PubMed         Abstract available


    J Biol Chem

  14. XI M, Zhao P, Li F, Bao H, et al
    MicroRNA-16 inhibits the TLR4/NF-kappaB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea.
    J Biol Chem. 2022 Sep 3:102461. doi: 10.1016/j.jbc.2022.102461.
    PubMed         Abstract available


    J Parasitol Res

  15. ROSHIDI N, Arifin N
    Disease Biomarkers of Giardiasis.
    J Parasitol Res. 2022;2022:1932518.
    PubMed         Abstract available


    Parasit Vectors

  16. FRANKLIN F, Rajamanikam A, Raju CS, Gill JS, et al
    Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.
    Parasit Vectors. 2022;15:313.
    PubMed         Abstract available


    Phys Med

  17. HUBBARD CRISTINACCE PL, Keaveney S, Aboagye EO, Hall MG, et al
    Clinical translation of quantitative magnetic resonance imaging biomarkers - An overview and gap analysis of current practice.
    Phys Med. 2022;101:165-182.
    PubMed         Abstract available


    Singapore Med J

  18. TAN ZE, Tan YQ, Lin H, How CH, et al
    Irritable bowel syndrome: an approach for primary care physicians.
    Singapore Med J. 2022;63:367-370.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: